We are live on ! Find out more
PCM

Polaris Capital Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 40.82%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+40.82%
3 Year Est. Return
+94.3%
5 Year Est. Return
+113.49%
10 Year Est. Return
+358.47%
AUM
$3.1B
AUM Growth
+$51.4M
Cap. Flow
+$102M
Cap. Flow %
3.28%
Top 10 Hldgs %
48.78%
Holding
106
New
4
Increased
29
Reduced
19
Closed
3

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$224M
2
NEE icon
NextEra Energy
NEE
+$1.22M
3
MTB icon
M&T Bank
MTB
+$1.11M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.01M
5
ALE
Allete
ALE
+$989K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$52.7M
2
DGX icon
Quest Diagnostics
DGX
+$44.3M
3
BPOP icon
Popular Inc
BPOP
+$18.6M
4
INFY icon
Infosys
INFY
+$13.8M
5
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$1.93M

Sector Composition

Rank Sector Weight
1 Financials 27.15%
2 Healthcare 18.38%
3 Technology 13.56%
4 Consumer Staples 10.23%
5 Consumer Discretionary 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPOP icon
1
Popular Inc
BPOP
$10.9B
$253M 8.16%
3,369,778
-243,100
-7% -$18.6M
JAZZ icon
2
Jazz Pharmaceuticals
JAZZ
$16B
$230M 7.41%
+1,292,760
New +$224M
CCEP icon
3
Coca-Cola Europacific Partners
CCEP
$48.1B
$209M 6.74%
3,520,083
-33,100
-0.9% -$1.93M
LIN icon
4
Linde
LIN
$234B
$178M 5.73%
614,403
-5,600
-0.9% -$1.63M
INFY icon
5
Infosys
INFY
$47.4B
$168M 5.42%
7,927,404
-724,300
-8% -$13.8M
AMCR icon
6
Amcor
AMCR
$20.9B
$152M 4.91%
2,656,254
-16,300
-0.6% -$970K
CROX icon
7
Crocs
CROX
$6.69B
$98.5M 3.18%
845,755
+6,300
+0.8% +$620K
COF icon
8
Capital One
COF
$127B
$79.1M 2.55%
511,508
+5,000
+1% +$754K
MPC icon
9
Marathon Petroleum
MPC
$91.2B
$73.3M 2.36%
1,213,094
+10,400
+0.9% +$610K
JPM icon
10
JPMorgan Chase
JPM
$947B
$72M 2.32%
462,851
+3,500
+0.8% +$550K
WBS icon
11
Webster Financial
WBS
$12.5B
$71.2M 2.3%
1,334,661
-30,300
-2% -$1.68M
UTHR icon
12
United Therapeutics
UTHR
$26.3B
$68.6M 2.21%
382,100
+1,600
+0.4% +$305K
CNK icon
13
Cinemark Holdings
CNK
$3.93B
$67.8M 2.19%
3,088,358
+23,200
+0.8% +$515K
ARW icon
14
Arrow Electronics
ARW
$10.9B
$63.3M 2.04%
556,003
+3,000
+0.5% +$351K
BERY
15
DELISTED
Berry Global Group, Inc.
BERY
$63.2M 2.04%
1,054,479
+3,921
+0.4% +$236K
CVS icon
16
CVS Health
CVS
$137B
$62.2M 2.01%
744,900
-2,100
-0.3% -$172K
CIB icon
17
Grupo Cibest SA
CIB
$20.9B
$60.7M 1.96%
2,108,950
-2,140
-0.1% -$66K
MSFT icon
18
Microsoft
MSFT
$2.89T
$58.4M 1.89%
215,726
+2,800
+1% +$712K
ABCB icon
19
Ameris Bancorp
ABCB
$5.77B
$58.2M 1.88%
1,149,265
+7,600
+0.7% +$408K
TSN icon
20
Tyson Foods
TSN
$21.4B
$54.9M 1.77%
744,663
+6,400
+0.9% +$497K
IBOC icon
21
International Bancshares
IBOC
$4.77B
$54.7M 1.77%
1,274,406
+9,100
+0.7% +$425K
ELV icon
22
Elevance Health
ELV
$82.1B
$54.2M 1.75%
142,051
+1,900
+1% +$726K
LH icon
23
Labcorp
LH
$24.7B
$54.2M 1.75%
228,805
+2,910
+1% +$663K
WMB icon
24
Williams Companies
WMB
$86.6B
$52.7M 1.7%
1,984,400
+19,400
+1% +$497K
ALE
25
DELISTED
Allete
ALE
$51.2M 1.65%
731,958
+14,200
+2% +$989K
1
2 3 4 5

Similar funds

HMH
Hackensack Meridian Health Edison, New Jersey $1.06B AUM 18.03% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return
KA
Kintegral Advisory New York $1.06B AUM 24.93% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return

Polaris Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Polaris Capital Management held 106 positions worth $3.1B, up 1.7% from $3.05B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Polaris Capital Management deployed $102M of net new capital in Q2 2021, opening 4 new positions and adding to 29 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 1,292,760 shares worth $230M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Quest Diagnostics, an estimated $44.3M trimmed.

  • Polaris Capital Management's largest Q2 2021 buy was Jazz Pharmaceuticals: 1,292,760 shares worth $230M.
  • Polaris Capital Management added most to NextEra Energy in Q2 2021, an estimated $1.22M increase.
  • Polaris Capital Management's biggest Q2 2021 reduction was Quest Diagnostics, cutting an estimated $44.3M.
  • Polaris Capital Management fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $52.7M.
  • Polaris Capital Management's ten largest holdings make up 49% of its $3.1B portfolio in Q2 2021.
  • Polaris Capital Management opened 4 new positions and closed 3 in Q2 2021.
  • Polaris Capital Management's portfolio value rose 1.7% quarter-over-quarter to $3.1B.

Based on Polaris Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.